Durham, North Carolina, 27705, United States
NCT Number: NCT01029015
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
This is an observational, physiology pilot study of subjects with overactive bladder, insomnia and normal subjects. No study drug will be given. All subjects will complete a one week sleep diary and a 3-day bladder diary. After one week, subjects meeting eligibility requirements will complete a single sleep night stay in a sleep laboratory setting. During the sleep night stay, subjects will be evaluated using cystometry and polysomnography. In the morning following the sleep night stay, subjects will complete a sleep questionnaire and this will complete their participation in the study.
Looking for future studies?
Notify MeKey information
Conditions
Age range
45 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Must not have a urinary tract infection
- Time in bed between 6.5 and 9 hours for at least 5 nights per week for preceding month
- Usual bed time is before midnight (24:00 hours) and typically does not vary by ± 1 hour for preceding month
- OAB subjects
- OAB symptoms for >= 3 months
- Documented detrusor overactivity episodes within 6 months
- Insomnia subjects
- Diagnosis of chronic primary insomnia
- History of > 1 month of waking up more than 2 times per night and being awake for more than 60 minutes per night for at least 3 months
Exclusion criteria
- Diagnosis of both OAB and primary insomnia
- Diagnosis of nocturnal polyuria
- Diagnosis of BPH
- BMI >= 34
Treatment and study plan
cystometry
Procedurerecording device measuring pressures though catheters placed in bladder and rectum
Polysomnography
Procedurerecording device measuring sleep activity through electrodes attached to the subject
Primary outcomes
-
Number and proportion of voids associated with urgency
Time frame: During night in sleep lab
-
Number and proportion of voids associated with Detrusor Overactivity episodes within 10 minutes prior to the polysomnography (PSG) awakenings
Time frame: During night in sleep lab
-
Time from PSG awakening to each void in minutes
Time frame: During night in sleep lab
Sponsors and collaborators
Lead sponsor
Astellas Pharma Inc
Industry
Collaborators
- GlaxoSmithKline
Registry information
Official study title
A Pilot, Phase 4, Sleep Laboratory Study Comparing the Physiology of Nocturnal Bladder Function in Subjects With Overactive Bladder - Associated Nocturia to Subjects With Primary Insomnia and Healthy Normal Subjects
Acronym: Nocturia Plt 1
Important dates
- Study start
- 2006
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Dec 9, 2009
- Registry last updated
- Mar 7, 2011
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Trendelenburg, Abdominal Insufflation and Time to Completion of Cystoscopy
NCT05786391
Bladder Function, Bladder Integrity
Houston, Texas, United States
View Trial DetailsECHO-012 Kosmos Bladder Clinical Validation Study
NCT06792851
Bladder Disease, Bladder Dysfunction
Renton, Washington, United States
View Trial DetailsSensory-Friendly Physical Activity for Sleep in Autistic Children
NCT07277101
Autism Spectrum Disorder, Autistic Disorder
Shanghai, China
View Trial DetailsThe Reducing Risk Study
NCT03665337
Delayed Sleep Phase, Dyssomnias
San Francisco, California, United States
View Trial Details